S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
作者信息
Frangogiannis Nikolaos G
机构信息
The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA.
出版信息
Eur Heart J. 2019 Aug 21;40(32):2724-2726. doi: 10.1093/eurheartj/ehz524.
Abstract
摘要
相似文献
1
S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.S100A8/A9作为心肌梗死的治疗靶点：细胞机制、分子相互作用及转化挑战
Eur Heart J. 2019 Aug 21;40(32):2724-2726. doi: 10.1093/eurheartj/ehz524.
2
S100A8/A9 in Myocardial Infarction.心肌梗死中的S100A8/A9
Methods Mol Biol. 2019;1929:739-754. doi: 10.1007/978-1-4939-9030-6_46.
3
S100A8/A9 as a prognostic biomarker with causal effects for post-acute myocardial infarction heart failure.S100A8/A9 作为一种预后生物标志物，对急性心肌梗死后心力衰竭具有因果效应。
Nat Commun. 2024 Mar 27;15(1):2701. doi: 10.1038/s41467-024-46973-7.
4
The Association Between S100A8/A9 and the Development of Very Late Stent Thrombosis in Patients With Acute Myocardial Infarction.S100A8/A9 与急性心肌梗死患者极晚期支架血栓形成的关系。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620943295. doi: 10.1177/1076029620943295.
5
S100A8/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury.S100A8/A9 增强人羊膜间充质干细胞在心肌缺血再灌注损伤中的免疫调节和组织修复特性。
Int J Mol Sci. 2021 Oct 16;22(20):11175. doi: 10.3390/ijms222011175.
6
S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.S100a8/a9 信号导致心肌细胞在缺血/再灌注损伤时发生线粒体功能障碍和死亡。
Circulation. 2019 Aug 27;140(9):751-764. doi: 10.1161/CIRCULATIONAHA.118.039262. Epub 2019 Jun 21.
7
S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.S100A8/A9 通过诱导巨噬细胞分泌 TNFα 促进心肌梗死后心脏破裂的成纤维细胞中 MMP-9 的表达。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3925-3935. doi: 10.26355/eurrev_201806_15278.
8
The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.肌成纤维细胞在结直肠癌微环境中上调 S100A8 和 S100A9 及髓系细胞分化中的作用。
Biochem Biophys Res Commun. 2012 Jun 22;423(1):60-6. doi: 10.1016/j.bbrc.2012.05.081. Epub 2012 May 22.
9
S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.S100A8 和 S100A9：固有免疫、传统危险因素和心血管疾病之间的 DAMPs 交汇点。
Mediators Inflamm. 2013;2013:828354. doi: 10.1155/2013/828354. Epub 2013 Dec 22.
10
Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients.急性心肌梗死患者 S100A8/A9 复合物表达增强。
Circ J. 2010 Apr;74(4):741-8. doi: 10.1253/circj.cj-09-0564. Epub 2010 Feb 27.
引用本文的文献
1
Systemic S100A8/A9 in patients with moderate to severe acute ischemic stroke: Exploratory analysis of inflammation and functional outcome.中重度急性缺血性脑卒中患者的全身S100A8/A9：炎症与功能转归的探索性分析
Brain Behav Immun Health. 2025 Jun 18;47:101041. doi: 10.1016/j.bbih.2025.101041. eCollection 2025 Aug.
2
Unraveling the Mechanisms of S100A8/A9 in Myocardial Injury and Dysfunction.解析S100A8/A9在心肌损伤和功能障碍中的作用机制
Curr Issues Mol Biol. 2024 Sep 2;46(9):9707-9720. doi: 10.3390/cimb46090577.
3
Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.循环钙卫蛋白水平作为冠状动脉疾病患者的生物标志物：系统评价和荟萃分析。
Clin Cardiol. 2024 Jul;47(7):e24315. doi: 10.1002/clc.24315.
4
Identification and validation of lipid metabolism-related key genes as novel biomarkers in acute myocardial infarction and pan-cancer analysis.鉴定和验证脂质代谢相关关键基因作为急性心肌梗死和泛癌分析的新型生物标志物。
Aging (Albany NY). 2024 May 23;16(10):9127-9146. doi: 10.18632/aging.205860.
5
Advances in brain-heart syndrome: Attention to cardiac complications after ischemic stroke.脑心综合征的进展：关注缺血性中风后的心脏并发症。
Front Mol Neurosci. 2022 Nov 24;15:1053478. doi: 10.3389/fnmol.2022.1053478. eCollection 2022.
6
S100A8/A9 drives the formation of procoagulant platelets through GPIbα.S100A8/A9 通过 GPIbα 驱动促凝血小板的形成。
Blood. 2022 Dec 15;140(24):2626-2643. doi: 10.1182/blood.2021014966.
7
Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population.中国人群中钙粒蛋白基因多态性与缺血性中风
J Inflamm Res. 2022 Jun 9;15:3355-3368. doi: 10.2147/JIR.S360775. eCollection 2022.
8
Neutrophil crosstalk during cardiac wound healing after myocardial infarction.心肌梗死后心脏伤口愈合过程中的中性粒细胞相互作用。
Curr Opin Physiol. 2021 Dec;24. doi: 10.1016/j.cophys.2022.100485. Epub 2022 Jan 31.
9
S100A8 and S100A9 are elevated in chronically threatened ischemic limb muscle and induce ischemic mitochondrial pathology in mice.S100A8和S100A9在慢性威胁性缺血肢体肌肉中升高，并在小鼠中诱导缺血性线粒体病理改变。
JVS Vasc Sci. 2022 Apr 21;3:232-245. doi: 10.1016/j.jvssci.2022.03.003. eCollection 2022.
10
C/EBPδ-induced epigenetic changes control the dynamic gene transcription of and .C/EBPδ 诱导的表观遗传变化控制着 和 的动态基因转录。
Elife. 2022 May 11;11:e75594. doi: 10.7554/eLife.75594.
本文引用的文献
1
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.短期 S100A9 阻断抑制促炎髓系细胞反应可改善心肌梗死后心功能。
Eur Heart J. 2019 Aug 21;40(32):2713-2723. doi: 10.1093/eurheartj/ehz461.
2
Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.心肌梗死的抗炎治疗：失败、希望与挑战。
Br J Pharmacol. 2018 May;175(9):1377-1400. doi: 10.1111/bph.14155. Epub 2018 Mar 4.
3
S100A8 and S100A9 Are Induced by Decreased Hydration in the Epidermis and Promote Fibroblast Activation and Fibrosis in the Dermis.S100A8 和 S100A9 由表皮水分减少诱导产生，并促进真皮成纤维细胞的激活和纤维化。
Am J Pathol. 2016 Jan;186(1):109-22. doi: 10.1016/j.ajpath.2015.09.005. Epub 2015 Nov 18.
4
Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.坏死的心肌细胞释放损伤相关分子模式，这些模式在体外可引发成纤维细胞活化，并在体内引发心肌炎症和纤维化。
J Am Heart Assoc. 2015 Jun 2;4(6):e001993. doi: 10.1161/JAHA.115.001993.
5
The inflammatory response in myocardial injury, repair, and remodelling.心肌损伤、修复及重塑中的炎症反应。
Nat Rev Cardiol. 2014 May;11(5):255-65. doi: 10.1038/nrcardio.2014.28. Epub 2014 Mar 25.
6
Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.S100A9 蛋白诱导核因子-κB 反应依赖 Toll 样受体 4。
Immunology. 2012 Oct;137(2):172-82. doi: 10.1111/j.1365-2567.2012.03619.x.
7
S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.S100A8/A9 通过激活 RAGE 依赖性 NF-κB 信号加重缺血性心力衰竭。
Basic Res Cardiol. 2012 Mar;107(2):250. doi: 10.1007/s00395-012-0250-z. Epub 2012 Feb 10.
8
Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients.急性心肌梗死患者 S100A8/A9 复合物表达增强。
Circ J. 2010 Apr;74(4):741-8. doi: 10.1253/circj.cj-09-0564. Epub 2010 Feb 27.
9
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.内源性Toll样受体4激动剂S100A8/S100A9（钙卫蛋白）作为感染、自身免疫和癌症的固有放大器。
J Leukoc Biol. 2009 Sep;86(3):557-66. doi: 10.1189/jlb.1008647. Epub 2009 May 18.
10
S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.S100A8和S100A9通过晚期糖基化终产物受体介导内毒素诱导的心肌细胞功能障碍。
Circ Res. 2008 May 23;102(10):1239-46. doi: 10.1161/CIRCRESAHA.107.167544. Epub 2008 Apr 10.
Zotero 插件